...
首页> 外文期刊>Annals of Clinical Microbiology and Antimicrobials >Systematic review of carbapenem-resistant Enterobacteriaceae causing neonatal sepsis in China
【24h】

Systematic review of carbapenem-resistant Enterobacteriaceae causing neonatal sepsis in China

机译:耐肠道肠杆菌的系统综述导致中国新生儿脓毒症

获取原文

摘要

Carbapenems are β-lactam antibiotics which are used to treat severe infections caused by multidrug resistant Enterobacteriacea. The recent emergence and rapid spread of Enterobacteriaceae resistant to carbapenems is a global concern. We undertook a systematic review of the antibiotic susceptibility and genotypic characteristics of carbapenem-resistant Enterobacteriaceae in Chinese neonates. Systematic literature reviews were conducted (PubMed/Medline, Embase, Wanfang medical online databases, China National Knowledge Infrastructure (CNKI) database) regarding sepsis caused by carbapenem-resistant Enterobacteriaceae in Chinese neonates aged 0-30?days. 17 studies were identified. Eleven patients in the six studies reported the source of infection. Ten patients (10/11, 90.9%) were hospital-acquired infections. Genotypic data were available for 21 isolates in 11 studies (20?K. pneumoniae, 1 E. coli). NDM-1 was the most frequently reported carbapenem-resistant genotype (81.0%, 17/21). Carbapenem-resistant Klebsiella pneumoniae and Escherichia coli were resistant to many antibiotic classes with the exception of colistin and fosfomycin. Sequence type 105 (ST105) was the most commonly reported K. pneumoniae ST type (30.8%; 4/13), which was from the same hospital in Western China. ST17 and ST20 were the second and third most common K. pneumoniae ST type, 23.1% (3/13) and 15.4% (2/13) respectively. The three strains of ST17 are all from the same hospital in central China. The two strains of ST20, although not from the same hospital, belong to the eastern part of China. Klebsiella pneumoniae with the NDM-1 genotype was the leading cause of neonatal carbapenem resistant sepsis in China. Hospital acquired infection is the main source of carbapenem resistant sepsis. There is currently no licenced antibiotic regimen available to treat such an infection in China. Improved surveillance, controlling nosocomial infection and the rational use of antibiotics are the key factors to prevent and reduce its spread.
机译:Carbapenems是β-内酰胺抗生素,用于治疗多药抗生素引起的严重感染。最近对肠杆菌的出现和快速传播抵抗CarbapeNems是全球担忧。我们对中国新生儿的抗生素抗生素肠杆菌的抗生素敏感性和基因型特征进行了系统审查。系统文献评论进行了(PubMed / Medline,Embase,Wanfang医疗在线数据库,中国全国知识基础设施(CNKI)数据库)关于由0-30岁的中国新生儿抗性肠杆菌的败血症引起的败血症引起的败血症。鉴定了17项研究。六项研究中的11名患者报告了感染源。 10名患者(10/11,90.9%)是医院收养的感染。基因型数据可用于11项研究中的21个分离物(20?K.Pneumoniae,1大肠杆菌)。 NDM-1是最常见的鲤鱼抗性基因型(81.0%,17/21)。除了Colistin和Fosfomcin外,Carbapenem抗性肺炎肺炎和大肠杆菌对许多抗生素类进行了抗性。序列型105(ST105)是最常见的K.肺炎肺炎群ST型(30.8%; 4/13),来自西部的同一医院。 ST17和ST20分别是第二和第三个最常见的K.肺炎肺炎,分别为23.1%(3/13)和15.4%(2/13)。 ST17的三个菌株都来自中国中部同一医院。 ST20的两个菌株虽然不是来自同一所在医院,属于中国东部。 Klebsiella肺炎与NDM-1基因型是中国新生儿Carbapenem抗脓毒症的主要原因。医院获得的感染是Carbapenem抗性脓毒症的主要来源。目前没有可用于治疗中国此类感染的许可抗生素方案。改善监测,控制医院感染和合理使用抗生素是预防和减少其蔓延的关键因素。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号